Published September 2016
| Version v1
Journal article
Research and development of HER2 expression molecular imaging
Creators
- 1. Hubei Province Key Laboratory of Molecular Imaging, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Nuclear Medicine and Molecular Imaging, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan (China)
Description
Human epidermal growth factor receptor-2(HER2) is a kind of transmembrane receptor with tyrosine kinase activity, and also is a biomarker highly expressed in various cancer cells, often indicating poor clinical prognosis. HER2 expression molecular imaging mainly utilizes the labeled-ligands' ability of specific binding with HER2, such as radionuclide, magnetic materials and fluorescent substances, by which the high-HER2 expressed lesions are shown. This technique provides a strong support for diagnosing HER2-expressed diseases, selecting patients who are respondent to HER2-targeted therapy and evaluating the therapeutic effect, and has become one of the hot spots in the research of precise treatment of tumors in recent years. (authors)
Additional details
Identifiers
Publishing Information
- Journal Title
- International Journal of Radiation Medicine and Nuclear Medicine
- Journal Volume
- 40
- Journal Issue
- 5
- Journal Page Range
- p. 363-373
- ISSN
- 1673-4114
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 51079485
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOLOGICAL MARKERS; DIAGNOSIS; FLUORESCENCE; GROWTH FACTORS; LIGANDS; NEOPLASMS; PATIENTS; PROBES; RADIOISOTOPES; RECEPTORS; THERAPY; TYROSINE
- Descriptors DEC
- AMINO ACIDS; CARBOXYLIC ACIDS; DISEASES; EMISSION; HYDROXY ACIDS; ISOTOPES; LUMINESCENCE; MEDICINE; MEMBRANE PROTEINS; MITOGENS; ORGANIC ACIDS; ORGANIC COMPOUNDS; PHOTON EMISSION; PROTEINS
Optional Information
- Notes
- 75 refs.; http://dx.doi.org/10.3760/cma.j.issn.1673-4114.2016.05.007